A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

NCT06983743 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Solid Tumors

Interventions

DRUG: ERAS-0015
DRUG: ERAS-0015 in combination

Sponsor

Erasca, Inc.